IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 333 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,436,636 | -16.9% | 163,947 | -34.5% | 0.02% | -28.1% |
Q1 2023 | $8,945,758 | +2.7% | 250,301 | +8.6% | 0.03% | +3.2% |
Q4 2022 | $8,706,929 | +10.8% | 230,525 | +29.8% | 0.03% | -13.9% |
Q3 2022 | $7,855,000 | +1677.1% | 177,597 | +1388.7% | 0.04% | +1700.0% |
Q2 2022 | $442,000 | +50.3% | 11,930 | +92.3% | 0.00% | +100.0% |
Q3 2020 | $294,000 | -95.7% | 6,204 | -94.7% | 0.00% | -97.1% |
Q2 2020 | $6,840,000 | +1390.2% | 116,012 | +1096.0% | 0.03% | +1033.3% |
Q1 2020 | $459,000 | -87.0% | 9,700 | -83.5% | 0.00% | -75.0% |
Q4 2019 | $3,544,000 | +9.0% | 58,670 | +8.2% | 0.01% | 0.0% |
Q3 2019 | $3,250,000 | -39.0% | 54,248 | -34.6% | 0.01% | -36.8% |
Q2 2019 | $5,331,000 | +214.0% | 82,955 | +296.5% | 0.02% | +216.7% |
Q1 2019 | $1,698,000 | +513.0% | 20,924 | +308.4% | 0.01% | +500.0% |
Q4 2018 | $277,000 | -55.5% | 5,124 | -57.6% | 0.00% | -50.0% |
Q3 2018 | $623,000 | -17.5% | 12,077 | -33.3% | 0.00% | -33.3% |
Q2 2018 | $755,000 | +271.9% | 18,109 | +293.7% | 0.00% | +200.0% |
Q1 2018 | $203,000 | – | 4,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |